Heterogeneity and interplay: the multifaceted role of cancer-associated fibroblasts in the tumor and therapeutic strategies
Clinical and Translational Oncology · 2024
DOI: 10.1007/s12094-024-03492-7 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Translational Oncology, 2024. Verfasst von Qiaoqiao Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-T…. Hauptthemen laut MEDLINE: Cancer-Associated Fibroblasts, Tumor Microenvironment, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 168 Literaturangaben. Gefördert von: Specific Research Project of Guangxi for Research Bases and Talents.
Abstract (Originalsprache)
The journey of cancer development is a multifaceted and staged process. The array of treatments available for cancer varies significantly, dictated by the disease's type and stage. Cancer-associated fibroblasts (CAFs), prevalent across various cancer types and stages, play a pivotal role in tumor genesis, progression, metastasis, and drug resistance. The strategy of concurrently targeting cancer cells and CAFs holds great promise in cancer therapy. In this review, we focus intently on CAFs, delving into their critical role in cancer's progression. We begin by exploring the origins, classification, and surface markers of CAFs. Following this, we emphasize the key cytokines and signaling pathways involved in the interplay between cancer cells and CAFs and their influence on the tumor immune microenvironment. Additionally, we examine current therapeutic approaches targeting CAFs. This article underscores the multifarious roles of CAFs within the tumor microenvironment and their potential applications in cancer treatment, highlighting their importance as key targets in overcoming drug resistance and enhancing the efficacy of tumor therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting T…
- Department of Oncology, The First Affiliated Tumor Hospital, Guangxi University of Chinese Medicine, Nanning, 530021, Guangxi, China. Shiwei1001@163.com.
Förderung
- Specific Research Project of Guangxi for Research Bases and Talents
Zitieren
APA
Liu, Q., Yao, F., Wu, L., Xu, T., Na, J., Shen, Z., Liu, X., Shi, W., Zhao, Y., & Liao, Y. (2024). Heterogeneity and interplay: the multifaceted role of cancer-associated fibroblasts in the tumor and therapeutic strategies. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-024-03492-7
Vancouver
Liu Q, Yao F, Wu L, Xu T, Na J, Shen Z, et al. Heterogeneity and interplay: the multifaceted role of cancer-associated fibroblasts in the tumor and therapeutic strategies. Clinical and Translational Oncology. 2024. doi:10.1007/s12094-024-03492-7
BibTeX
@article{Liu2024,
author = {Liu, Qiaoqiao and Yao, Fei and Wu, Liangliang and Xu, Tianyuan and Na, Jintong and Shen, Zhen and Liu, Xiyu and Shi, Wei and Zhao, Yongxiang and Liao, Yuan},
title = {Heterogeneity and interplay: the multifaceted role of cancer-associated fibroblasts in the tumor and therapeutic strategies},
journal = {Clinical and Translational Oncology},
year = {2024},
doi = {10.1007/s12094-024-03492-7}
}
EUVIMED